News2019-10-09T10:50:09-05:00

We’re in the News

Be Noble

Stay informed of Noble in the news as we advance our mission to create advanced drug delivery system trainers for the world’s leading pharmaceutical companies, which, in the end, benefit millions of patients worldwide.

Jan, 14, 202:33 pm

Response to News Release from 215 Biopharma KOLs

January 14th, 2020|adherence, autoinjector, compliance, Noble, patient onboarding, prefilled syringe, prefilled syringe trainer, prefilled syringe training, self-injection, training, Training Devices|

In the January 2020 edition of STAT News was a news release from 215 biopharma CEOs and industry leaders. The news release leverages 2020 as the beginning of “the dawn of a golden age [...]

Oct, 15, 1912:24 pm

Noble’s Self-Injection Trainers for Rheumatoid Arthritis Drugs

October 15th, 2019|adherence, autoinjector trainer, Device Training, Medgadget, Noble, prefilled syringe trainer, prefilled syringe training, self-injection, training, Training Devices|

Last year, Medgadget heard from Noble International about its smart training devices that educate patients on safe and effective at-home use of prefilled syringes and autoinjectors. At the time, Joe Reynolds, Research Manager at Noble International, shared [...]

Oct, 9, 193:58 pm

How Well Are Your Rheumatology Patients Self-Administering Their Medication?

October 9th, 2019|adherence, autoinjector, injection training, patient onboarding, prefilled syringe, prefilled syringe trainer, prefilled syringe training, self-injection, training|

A primary goal of rheumatologists remains alleviating the pain, stiffness and tenderness that mark rheumatoid arthritis (RA). Yet in an era marked by a significant increase in self-injection options, it has become crucial for [...]

Sep, 6, 198:37 am

Training Patients in The Use of Wearable Injectors

September 6th, 2019|adherence, Device Training, Noble, Onbody, Onbody trainers, Onbody training, OnDrugDelivery, patient onboarding, training|

Millions of patients worldwide living with rare, debilitating conditions are benefiting from developments in biopharmaceuticals and complex chemical entities as well as novel approaches to drug delivery. For example, many therapeutics administered in a [...]